PMVP Stock Summary and Trading Ideas (PMV Pharmaceuticals | NASDAQ:PMVP)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

PMV Pharmaceuticals trades on the NASDAQ stock market under the symbol PMVP.

As of December 31, 2025, PMVP stock price climbed to $1.25 with 325,248 million shares trading.

PMVP has a beta of 0.31, meaning it tends to be less sensitive to market movements. PMVP has a correlation of 0.01 to the broad based SPY ETF.

PMVP has a market cap of $66.51 million. This is considered a Micro Cap stock.

In the last 3 years, PMVP traded as high as $9.72 and as low as $.81.

The top ETF exchange traded funds that PMVP belongs to (by Net Assets): VTI, VXF, IWC.

PMVP has underperformed the market in the last year with a return of -16.1%, while the SPY ETF gained +17.2%. In the last 3 month period, PMVP fell short of the market, returning -10.7%, while SPY returned +2.7%. However, in the most recent 2 weeks PMVP has outperformed the stock market by returning +5.9%, while SPY returned +0.7%.

PMVP support price is $1.17 and resistance is $1.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PMVP shares will trade within this expected range on the day.